INSULET CORP

PODD

Held by 3 specialist biotech funds

High Convergence

Share on X

Fund Holdings

3 fund convergence

Driehaus Capital RTW Investments Deerfield Management

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 49,372Value: $14.0M

# Signal Note: Driehaus Initiates $14M PODD Position Driehaus Capital's new $14M stake in Insulet signals conviction in the Omnipod insulin delivery platform's market expansion, likely driven by recent FDA approvals (Omnipod 5 full automation clearance in 2023) and growing type 1 diabetes adoption among pediatric and adult populations. The position timing aligns with Insulet's international expansion efforts and reimbursement tailwinds, though the stock remains sensitive to competitive insulin pump launches and GLP-1 market dynamics that could impact traditional insulin utilization.

RTW InvestmentsNEW

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

NBIX3 funds BBNX3 funds SYRE3 funds ARWR3 funds CELC3 funds CMPS3 funds TNDM2 funds NUVL

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief:

AI Signal

AI analyst context — unlock full analysis

# Signal Note: RTW Investments Initiates $92.3M PODD Position RTW's new $92.3M stake in Insulet signals confidence in the Omnipod platform's competitive moat in insulin delivery, likely driven by recent clinical validation (Omnipod 5 reimbursement expansion) and durable recurring revenue from its installed base. The position size ($92.3M) represents meaningful conviction from a data-focused investor, suggesting conviction in PODD's ability to capture market share in the growing automated insulin delivery market ahead of competitor launches. Watch for Q3 subscriber growth and international expansion metrics as key catalysts validating the thesis.